All

× UPDATE! Updated as of 30 September 2024.
Records 21 to 40 of 34750
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1059 Somatropin Scitropin A 5 mg/ 1.5 mL (15IU) Solution S.C. for Injection Prescription Drug (RX) Anterior Pituitary Lobe Hormone and Analogue SANDOZ GmbH Austria Renewal 01 November 2023 27 November 2028
View BR-1068 Trastuzumab Herceptin 150 mg Lyophilized Powder For Concentrate Solution For Infusion (IV) Prescription Drug (RX) - Genentech, Inc. United States of America Initial (Variation) 11 October 2022 11 October 2027
View BR-1072_PI_01.pdf BR-1072 Ranibizumab Lucentis 10 mg/mL Solution For Injection (Intravitreal) Prescription Drug (RX) Antineovascular agents Novartis Pharma Stein AG Switzerland Renewal 31 May 2024 29 May 2029
View BR-1073 Filgrastim Neubicyte 150 mcg/mL Solution for Injection/ 150mg/ml Prescription Drug (RX) Hematopoietic Growth Factor Harbin Pharmaceutical Group Bioengineering Co., Ltd. China Renewal 20 June 2022 26 May 2027
View BR-1084_PI_01.pdf BR-1084 Quadrivalent Seasonal Influenza Vaccine (Split) Virion, Inactivated) 2024 Southern Hemisphere Strain. Fluquadri Formulation: Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/4897/2022 (H1N1) pdm09-like strain 15 μg of HA** (A/Victoria/4897/2022, IVR-238) A/Thailand/8/2022 (H3N2)-like strain 15 μg of HA** (A/California/122/2022, SAN-022) B/Austria/1359417/2021-like strain 15 μg of HA** (B/Michigan/01/2021, wild type) B/Phuket/3073/2013 (B/Yamagata lineage)-like virus 15 μg of HA** (B/Phuket/3073/2013, wild type) *Propagated in embryonated chicken eggs Suspension for Injection (IM) Prescription Drug (Rx) Vaccines Sanofi Pasteur U.S.A Monitored Release (Strain Clearance) 05 April 2024 05 April 2025
View BR-1091 Epoetin beta Recormon 2,000 I.U./0.3mL Solution for Injection (S.C./I.V.) Prescription Drug (Rx) Antianemic Preparations Roche Diagnostic GmbH Germany Renewal 18 September 2021 05 November 2026
View BR-1093 Alteplase Actilyse 50 mg Powder for Solution for Infusion (IV Prescription Drug (RX) - Boehringer Ingelheim Pharma GmbH & Co. KG Germany Initial (Variation) 19 September 2022 19 September 2027
View BR-1101_PI_01.pdf BR-1101 Tocilizumab Actemra 162 mg/ 0.9 mL Solution For Injection (SC) Prescription Drug (RX) - Vetter Pharma-Fertigung GmbH & Co. KG Germany - 08 March 2022 28 July 2025
View BR-1121 Trastuzumab Herceptin 600 mg/ 5 mL (120 mg/ mL) Solution For Injection (SC) Prescription Drug (RX) - F. Hoffmann-La Roche AG Switzerland Regular Renewal (Compliance) 07 March 2022 29 September 2025
View BR-1122 Rituximab Mabthera 1400 mg/ 11.7 mL Solution For Injection (SC) Prescription Drug (RX) - F. Hoffman-La Roche AG Switzerland Regular Renewal (Compliance) 18 February 2022 29 September 2025
View BR-1123 Obinutuzumab Gazyva 1 g/40 mL (25mg/mL) Concentrate For Solution For Infusion (IV) Prescription Drug (RX) - Roche Diagnostics GmbH Germany Initial (Variation) 12 August 2022 12 August 2027
View BR-1125_PI_01.pdf BR-1125 Quadrivalent Seasonal Influenza Vaccine (Split Virion, Inactivated) Southern Hemisphere 2024 Strain. Fluarix Tetra Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, IVR-237) B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) [Yamagata lineage] *Propagated in embryonated chicken eggs **Haemagglutinin 15 μg of HA** 15 μg of HA** 15 μg of HA** 15 μg of HA** Suspension for Injection (IM) Prescription Drug (RX) Vaccines GlaxoSmithKline Biologicals NL Der SmithKline Germany Monitored Release (Strain Clearance) 19 February 2024 19 February 2025
View BR-1126 Secukinumab Cosentyx 150 mg/mL Solution For Injection (SC) Prescription Drug (RX) Interleukin Inhibitors Novartis Pharma Stein AG Switzerland Initial (from Monitored Release) 12 April 2022 06 January 2026
View BR-1127 Secukinumab Scapho 150 mg Powder For Solution For Injection (SC) Prescription Drug (RX) Interleukin Inhibitors Novartis Pharma Stein AG, Pharmaceutical Switzerland Initial (from Monitored Release) 07 April 2022 14 January 2026
View BR-1130_PI_01.pdf BR-1130 Secukinumab Scapho 150 mg/mL Solution For Injection (Sc) Prescription Drug (RX) - Novartis Pharma Stein AG, Pharmaceutical Switzerland Initial (from Monitored Release) 11 April 2022 06 January 2026
View BR-1133 Pneumococcal Conjugate Vaccine, 13-Valent (adsorbed) [See formulation on reverse side] Prevenar 13 0.5 mL Suspension For Injection (IM) Prescription Drug (RX) - Pfizer Ireland Pharmaceuticals Ireland - 10 September 2021 21 January 2026
View BR-1135 Chorionic Gonadotrophin Chorapur 5000 IU Powder for Injection (IM) Prescription Drug (RX) - Ferring GmbH Germany - 08 March 2021 09 February 2026
View BR-1138 Pembrolizumab Keytruda 100mg/4mL (25mg/mL Solution For Injection (IV Infusion) Prescription Drug (RX) Antineoplastic MSD International GmbH T/A MSD Ireland (Carlow) Ireland Initial 06 July 2021 17 February 2026
View BR-1141 Rituximab Mabthera 10 mg/ mL Concentrate For Solution For Infusion (IV) Prescription Drug (RX) - Roche Diagnostic GmbH Germany - 08 March 2021 24 November 2025
View BR-1148 Combined Diphtheria, Tetanus, Acellular Pertussis Vaccine, Adsorbed Boostrix Formulation: 1 dose (0.5 mL) contains: Diphtheria toxoid*-Not less than 2 IU (2.5Lf) Tetanus toxoid*-Not less than 20 IU (5Lf) Pertussis toxoid (PT)*-8mcg Filamentous Hemagglutinin (FHA)*-8mcg Pertactin-2.5mcg *adsorbed on Aluminum hydroxide, hydrated (Al(OH)3)-300 mcg Al3 and Aluminum phosphate (AlPO4)-200 mcg A13+ Suspension For Injection (I.M.) Prescription Drug (RX) Vaccine GlaxoSmithKline Biologicals SA Belgium Renewal 27 April 2021 03 June 2026